CNTA vs TROW · $6.15B cap vs P/E 12, rev $3.76B
Centessa Pharmaceuticals PLC ADR (CNTA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
CNTA currently screens at market cap $6.15B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the CNTA and TROW stock pages for the full models.
Not investment advice.